P/E at 59.6 vs Industry's 58.2: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Slight Premium Reflects Market Confidence

The P/E ratio of Apollo Hospitals Enterprise Ltd. at 59.59 stands just above the hospital sector’s average of 58.16. This represents a premium of approximately 2.4%, indicating that investors are willing to pay slightly more for the stock relative to its peers. Such a premium often suggests expectations of superior earnings growth or operational resilience. However, the narrow margin also signals that the market’s valuation is closely aligned with sector fundamentals rather than reflecting an outsized optimism. Apollo Hospitals Enterprise Ltd.’s market capitalisation of ₹1,16,963.07 crore places it firmly in the large-cap category, underscoring its established position within the hospital sector.

Performance Across Timeframes: Strong Long-Term Gains Amid Short-Term Fluctuations

Examining the stock’s returns reveals a compelling divergence between short- and long-term performance. Over the past year, Apollo Hospitals Enterprise Ltd. has delivered a robust 19.66% gain, significantly outperforming the Sensex’s 8.40% loss during the same period. This outperformance extends over longer horizons, with three-year returns at 63.76% versus the Sensex’s 18.24%, five-year returns at 137.41% compared to 41.58%, and an impressive ten-year return of 494.40% against the Sensex’s 175.50%.

However, the recent three-month performance tells a more cautious story. The stock has gained 4.39% in this period, which, while positive, lags behind the sharper declines seen in the Sensex (-7.83%). The one-month return of 6.48% also outpaces the Sensex’s -3.85%, but the one-week figure shows a 1.71% decline, albeit less severe than the Sensex’s 2.52% fall. This pattern suggests that while Apollo Hospitals Enterprise Ltd. maintains resilience relative to the broader market, short-term volatility has increased — is this a temporary correction or a sign of shifting investor sentiment? The stock’s day performance today shows a modest gain of 0.47%, contrasting with the Sensex’s 0.93% decline, indicating some intraday strength.

Moving Average Configuration: Mixed Signals Point to Consolidation

The technical picture for Apollo Hospitals Enterprise Ltd. reveals a nuanced trend. The stock currently trades above its 20-day, 50-day, 100-day, and 200-day moving averages, signalling underlying medium- to long-term strength. However, it remains below its 5-day moving average, suggesting some near-term resistance or consolidation. This configuration often indicates a stock that is in a recovery phase following a short-term pullback but has not yet fully regained immediate momentum. The recent gain after three consecutive days of decline supports this interpretation — is this a genuine recovery or a dead-cat bounce?

Sector Performance Context: Hospital Industry Shows Mixed Results

The hospital sector, to which Apollo Hospitals Enterprise Ltd. belongs, has experienced a varied performance landscape. While some companies have reported positive earnings growth and stock appreciation, others have faced headwinds from regulatory pressures and rising costs. The sector’s average P/E of 58.16 reflects a valuation level that balances growth prospects with these challenges. Within this context, Apollo Hospitals Enterprise Ltd.’s slight premium suggests it is viewed as a relatively stable and well-managed player, though not immune to sector-wide fluctuations.

Rating Reassessment: Previously Hold, Now Updated

On 11 May 2026, the rating for Apollo Hospitals Enterprise Ltd. was updated from a previous Hold rating by MarketsMOJO. While the current rating is not disclosed, the reassessment reflects a comprehensive review of the company’s fundamentals, valuation, and technical indicators. This change invites investors to consider the latest data carefully — what is the current rating for Apollo Hospitals Enterprise Ltd.?

Collective Data Insights: Balancing Valuation and Momentum

The data for Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock with solid long-term performance and a valuation slightly above its sector peers. The premium P/E ratio suggests the market attributes some growth or quality advantage, yet the narrow margin tempers expectations. The stock’s recent price action and moving average configuration indicate a phase of consolidation or mild recovery after short-term weakness. This is consistent with the mixed short-term returns, which contrast with the strong gains over one, three, five, and ten years.

Investors may find the juxtaposition of strong historical returns and recent volatility noteworthy — should investors in Apollo Hospitals Enterprise Ltd. hold, buy more, or reconsider?

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today